Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PROF

Profound Medical (PROF)

Profound Medical Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PROF
DateTimeSourceHeadlineSymbolCompany
06/14/20245:23PMEdgar (US Regulatory)Form F-X - Appointment of Agent for Service of Process and UndertakingNASDAQ:PROFProfound Medical Corporation
06/14/20245:01PMEdgar (US Regulatory)Form F-10 - Registration Statement for Securities of certain Canadian Issuers.NASDAQ:PROFProfound Medical Corporation
06/14/20244:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
06/03/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
05/15/20245:00PMGlobeNewswire Inc.Profound Medical Annual General Meeting of Shareholders Voting ResultsNASDAQ:PROFProfound Medical Corporation
05/15/20244:12PMPR Newswire (Canada)PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTSNASDAQ:PROFProfound Medical Corporation
05/14/20249:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
05/14/20247:30AMGlobeNewswire Inc.Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment PlanNASDAQ:PROFProfound Medical Corporation
05/09/20244:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
05/09/20244:05PMGlobeNewswire Inc.Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue GuidanceNASDAQ:PROFProfound Medical Corporation
05/06/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
05/06/20244:15PMGlobeNewswire Inc.Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease SpectrumNASDAQ:PROFProfound Medical Corporation
04/22/20244:15PMGlobeNewswire Inc.Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
04/09/20247:45AMGlobeNewswire Inc.Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:PROFProfound Medical Corporation
03/07/20244:05PMGlobeNewswire Inc.Profound Medical Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
03/04/20244:30PMGlobeNewswire Inc.Profound Medical to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
02/27/20247:45AMGlobeNewswire Inc.Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA ProcedureNASDAQ:PROFProfound Medical Corporation
02/15/20244:30PMGlobeNewswire Inc.Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
01/16/20244:30PMGlobeNewswire Inc.Profound Medical Announces Non-Brokered Private PlacementNASDAQ:PROFProfound Medical Corporation
01/03/20244:15PMGlobeNewswire Inc.Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 RevenuesNASDAQ:PROFProfound Medical Corporation
12/27/202310:40PMGlobeNewswire Inc.Profound Medical Announces Pricing of US$20 Million Public Offering of Common SharesNASDAQ:PROFProfound Medical Corporation
12/27/20234:15PMGlobeNewswire Inc.Profound Medical Announces Proposed Public Offering of Common SharesNASDAQ:PROFProfound Medical Corporation
11/08/20237:45AMGlobeNewswire Inc.Profound Medical to Participate in the Stifel 2023 Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
11/03/20238:00AMGlobeNewswire Inc.Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC SettingNASDAQ:PROFProfound Medical Corporation
11/02/20234:05PMGlobeNewswire Inc.Profound Medical Announces Third Quarter 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
10/19/20234:30PMGlobeNewswire Inc.Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
10/10/20234:30PMGlobeNewswire Inc.Profound Medical 2023 Virtual Analyst & Investor Day AgendaNASDAQ:PROFProfound Medical Corporation
09/25/20234:05PMGlobeNewswire Inc.Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal BoostNASDAQ:PROFProfound Medical Corporation
09/21/20238:00AMGlobeNewswire Inc.Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13NASDAQ:PROFProfound Medical Corporation
09/19/20234:45PMGlobeNewswire Inc.Profound Medical to Participate in the 2023 Cantor Global Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
 Showing the most relevant articles for your search:NASDAQ:PROF